PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-8.32%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$629M
AUM Growth
+$629M
(-24%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
47.7%
Holding
242
New
26
Increased
27
Reduced
24
Closed
38
Top Buys
| 1 |
Glaukos
GKOS
|
$36.2M |
| 2 |
Guardant Health
GH
|
$16.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 4 |
Lyra Therapeutics
LYRA
|
$11.6M |
| 5 |
Pulmonx
LUNG
|
$10.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$19M |
| 2 |
C4 Therapeutics
CCCC
|
$15.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.5M |
| 4 |
ICU Medical
ICUI
|
$12.8M |
| 5 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$11.3M |
Sector Composition
| 1 | Healthcare | 90.17% |
| 2 | Industrials | 0.83% |
| 3 | Consumer Staples | 0.74% |
| 4 | Materials | 0.31% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $53.8M | 3.12% | 988,713 +26,219 | +3% | +$1.43M |
|
|
CUTR
2
DELISTED
Cutera, Inc.
CUTR
| $41.9M | 2.44% | 1,118,158 +44,007 | +4% | +$1.65M |
|
3
Inspire Medical Systems
INSP
$2.77B
| $37.4M | 2.17% | 204,465 +1,023 | +0.5% | +$187K |
|
|
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
| $36.8M | 2.13% | 13,869,108 +307,300 | +2% | +$814K |
|
|
5
Glaukos
GKOS
$5.5B
| $36.2M | 2.1% | +796,600 | New | +$36.2M |
|
6
Biogen
BIIB
$19.4B
| $20.7M | 1.2% | 101,711 -45,424 | -31% | -$9.26M |
|
|
7
Pulmonx
LUNG
$69.7M
| $19.5M | 1.13% | 1,327,065 +737,343 | +125% | +$10.9M |
|
|
8
Guardant Health
GH
$8.41B
| $18.9M | 1.1% | 469,492 +401,117 | +587% | +$16.2M |
|
|
NSTG
9
DELISTED
NanoString Technologies, Inc.
NSTG
| $18.7M | 1.08% | 1,469,547 +249,215 | +20% | +$3.16M |
|
|
IMDX
10
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $16.2M | 0.94% | 18,056,274 +5,832,321 | +48% | +$5.25M |
|
11
LivaNova
LIVN
$3.08B
| $16M | 0.93% | 256,848 -90,650 | -26% | -$5.66M |
|
|
12
Lyra Therapeutics
LYRA
$11.5M
| $14.6M | 0.85% | 2,576,196 +2,055,652 | +395% | +$11.6M |
|
13
United Therapeutics
UTHR
$13.8B
| $14.3M | 0.83% | 60,650 +44,089 | +266% | +$10.4M |
|
14
Lantheus
LNTH
$3.73B
| $14M | 0.81% | 212,238 -10,000 | -4% | -$660K |
|
|
15
Alnylam Pharmaceuticals
ALNY
$58.5B
| $13.9M | 0.81% | +95,240 | New | +$13.9M |
|
16
STAAR Surgical
STAA
$1.36B
| $13.9M | 0.81% | 195,810 -264 | -0.1% | -$18.7K |
|
17
AstraZeneca
AZN
$248B
| $10.8M | 0.62% | 162,828 +132,828 | +443% | +$8.78M |
|
18
Cooper Companies
COO
$13.4B
| $10.2M | 0.59% | 32,500 +19,500 | +150% | +$6.11M |
|
|
SLGC
19
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $9.6M | 0.56% | 2,123,120 -352,695 | -14% | -$1.59M |
|
20
KalVista Pharmaceuticals
KALV
$678M
| $8M | 0.46% | 812,828 +771,435 | +1,864% | +$7.59M |
|
21
Apyx Medical
APYX
$75.3M
| $7.76M | 0.45% | 1,323,303 +340,620 | +35% | +$2M |
|
22
Quanterix
QTRX
$211M
| $7.08M | 0.41% | +437,500 | New | +$7.08M |
|
23
Evolent Health
EVH
$1.12B
| $7.06M | 0.41% | 230,000 +30,000 | +15% | +$921K |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.88M | 0.4% | 715,144 -150,000 | -17% | -$1.44M |
|
25
Outset Medical
OM
$247M
| $6.59M | 0.38% | 443,701 -31,200 | -7% | -$464K |
|